Melia E, Parsons J
Cancers (Basel). 2024; 16(17).
PMID: 39272874
PMC: 11394570.
DOI: 10.3390/cancers16173016.
Xiong C, Ling H, Huang Y, Dong H, Xie B, Hao Q
Sci China Life Sci. 2024; 68(1):204-218.
PMID: 39245684
DOI: 10.1007/s11427-023-2589-1.
Chouhan S, Sridaran D, Weimholt C, Luo J, Li T, Hodgson M
Nat Commun. 2024; 15(1):5629.
PMID: 38965223
PMC: 11224269.
DOI: 10.1038/s41467-024-49978-4.
Sato Y, Habara M, Hanaki S, Sharif J, Tomiyasu H, Miki Y
Sci Rep. 2024; 14(1):14732.
PMID: 38926604
PMC: 11208570.
DOI: 10.1038/s41598-024-65769-9.
Takado M, Yamamoto T, Chikashige Y, Matsumoto T
Open Biol. 2024; 14(1):230379.
PMID: 38166399
PMC: 10762435.
DOI: 10.1098/rsob.230379.
Cyclers' kinases in cell division: from molecules to cancer therapy.
Milletti G, Colicchia V, Cecconi F
Cell Death Differ. 2023; 30(9):2035-2052.
PMID: 37516809
PMC: 10482880.
DOI: 10.1038/s41418-023-01196-z.
Synthetic and Medicinal Chemistry Approaches Toward WEE1 Kinase Inhibitors and Its Degraders.
Alli V, Yadav P, Suresh V, Jadav S
ACS Omega. 2023; 8(23):20196-20233.
PMID: 37323408
PMC: 10268025.
DOI: 10.1021/acsomega.3c01558.
Post-translational modifications of histones: Mechanisms, biological functions, and therapeutic targets.
Liu R, Wu J, Guo H, Yao W, Li S, Lu Y
MedComm (2020). 2023; 4(3):e292.
PMID: 37220590
PMC: 10200003.
DOI: 10.1002/mco2.292.
Wee1 epigenetically modulates H2B mono-ubiquitination at K120 lysine and DNA double-strand break repair through phosphorylation of H2BY37-dependent manner in small-cell lung cancer.
Zhao X, Wen X, Liu B
Thorac Cancer. 2023; 14(16):1420-1429.
PMID: 37102239
PMC: 10234777.
DOI: 10.1111/1759-7714.14862.
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance.
Sridaran D, Chouhan S, Mahajan K, Renganathan A, Weimholt C, Bhagwat S
Nat Commun. 2022; 13(1):6929.
PMID: 36376335
PMC: 9663509.
DOI: 10.1038/s41467-022-34724-5.
Combined evaluation of both WEE1 and phosphorylated cyclin dependent kinase 1 expressions in oral squamous cell carcinomas predicts cancer recurrence and progression.
Wu Y, Yu-Fong Chang J, Chiang C, Wang Y
J Dent Sci. 2022; 17(4):1780-1787.
PMID: 36299328
PMC: 9588842.
DOI: 10.1016/j.jds.2022.08.009.
SHP-1 dephosphorylates histone H2B to facilitate its ubiquitination during transcription.
Tathe P, Chowdary K, Murmu K, Prasad P, Maddika S
EMBO J. 2022; 41(19):e109720.
PMID: 35938192
PMC: 9531295.
DOI: 10.15252/embj.2021109720.
TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability.
Chouhan S, Sawant M, Weimholt C, Luo J, Sprung R, Terrado M
Autophagy. 2022; 19(3):1000-1025.
PMID: 35895804
PMC: 9980697.
DOI: 10.1080/15548627.2022.2103961.
Targeting DNA repair pathway in cancer: Mechanisms and clinical application.
Wang M, Chen S, Ao D
MedComm (2020). 2022; 2(4):654-691.
PMID: 34977872
PMC: 8706759.
DOI: 10.1002/mco2.103.
Loss of Long Noncoding RNA in Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide Resistance.
Ghildiyal R, Sawant M, Renganathan A, Mahajan K, Kim E, Luo J
Cancer Res. 2021; 82(1):155-168.
PMID: 34740892
PMC: 8732311.
DOI: 10.1158/0008-5472.CAN-20-3845.
Wee1 Kinase: A Potential Target to Overcome Tumor Resistance to Therapy.
Esposito F, Giuffrida R, Raciti G, Puglisi C, Forte S
Int J Mol Sci. 2021; 22(19).
PMID: 34639030
PMC: 8508993.
DOI: 10.3390/ijms221910689.
Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network.
Wu X, Wang L, Pearson N, Renuse S, Cheng R, Liang Y
Cancers (Basel). 2021; 13(16).
PMID: 34439388
PMC: 8394654.
DOI: 10.3390/cancers13164234.
Dissecting regulatory pathways for transcription recovery following DNA damage reveals a non-canonical function of the histone chaperone HIRA.
Bouvier D, Ferrand J, Chevallier O, Paulsen M, Ljungman M, Polo S
Nat Commun. 2021; 12(1):3835.
PMID: 34158510
PMC: 8219801.
DOI: 10.1038/s41467-021-24153-1.
Clinical Candidates Targeting the ATR-CHK1-WEE1 Axis in Cancer.
Gorecki L, Andrs M, Korabecny J
Cancers (Basel). 2021; 13(4).
PMID: 33672884
PMC: 7918546.
DOI: 10.3390/cancers13040795.
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance.
Lamballe F, Ahmad F, Vinik Y, Castellanet O, Daian F, Muller A
Adv Sci (Weinh). 2021; 8(3):2003049.
PMID: 33552868
PMC: 7856896.
DOI: 10.1002/advs.202003049.